Skip to content

Evaluation of an Innovative Mobile Health Based Integrated Modality for Smoking Cessation in Chinese smokers

Construction and evaluation of an online integrated modality for smoking cessation service in a general hospital

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066427
Enrollment
Unknown
Registered
2022-12-05
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking/Tobacco use disorder

Interventions

WQ modality-based treatment group:Integrated mHealth-based interventions based on the WQ modality for 4 weeks,including the QUIT WeChat mini program (WMP), the QUIT WeChat group (WG), and the QUIT WeC
quitline-based treatment group:Standard proactive quitline services (i.e., the counselor calls the smoker) from China Professional Quitline (400-888-5531) for 4 weeks using a multi-call quitline proto

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18–65 years of age; 2.smoked at least 100 cigarettes in lifetime; 3.currently smoke at least 5 cigarettes per day; 4.willing to make a quit attempt within 1 month; 5.possess a smartphone and a WeChat account, and could operate WeChat app skillfully; 6.promise to complete follow-up on time.

Exclusion criteria

Exclusion criteria: 1.difficult to understand the questionnaire; 2.acute exacerbation of chronic cardiopulmonary disease; 3.having received coronary surgical intervention (such as coronary angiography, percutaneous coronary intervention, etc.) in the last month or will receive these intervention in the next month; 4.within 1 month after discharge; 5.medical condition that precludes the use of NRT; 6.currently use smoking cessation medications or other aids, including nicotine replacement therapy, bupropion, varenicline, e-cigarettes and other mHealth-based tools, such as web, short message, apps, etc.; 7.enrolled in another smoking cessation study.

Design outcomes

Primary

MeasureTime frame
Biologically validated 7-day point prevalence abstinence rate;

Secondary

MeasureTime frame
Self-reported 7-day point prevalence abstinence rate at 3-month follow-up;Self-reported 7-day point prevalence abstinence rate at 6-month follow-up;Self-reported 7-day point prevalence abstinence rate at 12-month follow-up;Self-reported prolonged abstinence rate from 1-12 month;Quit attempt rates at 1 month/3months/6 months/12 months follow-ups;Acceptability and satisfaction scores for smoking cessation hotlines and WQ based smoking cessation services;incremental cost-effectiveness ratio (ICER) of the services;Self-reported 7-day point prevalence abstinence rate at 1-month follow-up;

Countries

China

Contacts

Public ContactLiang Lirong

Beijing Chao-Yang Hospital, Capital Medical University

llrcruie@163.com+86 010 85231610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 23, 2026